There are 2949 resources available
967P - Metastases harbored in the maxillofacial region: A retrospective review of patient and tumour characteristics
Presenter: Shahar Turgeman
Session: E-Poster Display
Resources:
Abstract
968P - Neoadjuvant nivolumab (N) plus weekly carboplatin (C) and paclitaxel (P) outcomes in HPV(-) resectable locally advanced head and neck cancer
Presenter: Ralph Zinner
Session: E-Poster Display
Resources:
Abstract
969P - Comparison of outcomes of weekly paclitaxel versus weekly cisplatin in oral cavity, oropharyngeal and hypopharyngeal cancer patients with concurrent radiation: A randomized controlled trial
Presenter: Kannikanti Durga Harika
Session: E-Poster Display
Resources:
Abstract
970P - MEDINDUCTION: Phase I trial evaluating the safety of durvalumab in combination with docetaxel, cisplatin and 5-FU (DCF) as induction therapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN)
Presenter: Caroline Even
Session: E-Poster Display
Resources:
Abstract
971P - Clinical and pathological characteristics of orbital tumours in patients diagnosed at the united states
Presenter: Dina El-Habashy
Session: E-Poster Display
Resources:
Abstract
972TiP - Phase II study of intratumoral MK-1454 plus pembrolizumab compared with pembrolizumab monotherapy as first-line treatment for metastatic or unresectable, recurrent head and neck squamous cell carcinoma
Presenter: Kevin Harrington
Session: E-Poster Display
Resources:
Abstract
973TiP - LEAP-010: Phase III study of first-line pembrolizumab with or without lenvatinib in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)
Presenter: Lillian Siu
Session: E-Poster Display
Resources:
Abstract
974TiP - Exploratory phase Ib/IIa study of intratumorally administered tigilanol tiglate to assess safety, tolerability and tumour response in patients with head and neck squamous cell carcinoma
Presenter: Richard Gallagher
Session: E-Poster Display
Resources:
Abstract
975TiP - Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma
Presenter: Xiuning Le
Session: E-Poster Display
Resources:
Abstract
976TiP - SPEARHEAD-2 trial design: A phase II pilot trial of ADP-A2M4 in combination with pembrolizumab in patients with recurrent or metastatic head and neck cancer
Presenter: Ezra Cohen
Session: E-Poster Display
Resources:
Abstract